ArticleActa biochimica et biophysica Sinica2022

HOXA13 serves as a biomarker to predict neoadjuvant therapy efficacy in advanced colorectal cancer patients.

Shuanghui Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.